Original Research
Accepted on 03 Jun 2025
NR1H4 and IL4R as diagnostic biomarkers in OCCC
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1600808
Type at least 3 characters
1,950 articles
Review
Accepted on 02 Jun 2025
Hormonal Modulation, Mitochondria and Alzheimer's Prevention: The Role of GLP-1 Agonists and Estrogens
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1622186
- 158 views
Original Research
Accepted on 30 May 2025
Integrated multi-omics analysis reveals the immunotherapeutic significance of tumor cells with high FN1 expression in ovarian cancer
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1611964
- 182 views
Original Research
Published on 30 May 2025
An immune-related seven-gene signature for predicting lymph node metastasis in breast cancer
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1615524
- 578 views
Original Research
Accepted on 27 May 2025
Mechanism of Shi-Yang-Xiao Lotion in Alleviating Perianal Eczema based on Network Pharmacology and Experimental Validation
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1621398
- 237 views
Original Research
Published on 27 May 2025
Enhanced prognostic and immunomodulatory effects of novel cuproptosis-related long noncoding RNAs in wilms tumor
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1566551
- 665 views
Review
Published on 26 May 2025
Linking oxidative stress biomarkers to disease progression and antioxidant therapy in hypertension and diabetes mellitus
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1611842
- 1,137 views
Review
Published on 26 May 2025
Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapies
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1573618
- 947 views
Original Research
Published on 26 May 2025
A telomere-associated molecular landscape reveals immunological, microbial, and therapeutic heterogeneity in colorectal cancer
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1615533
- 815 views
Original Research
Accepted on 22 May 2025
Identification of Hub Genes in Myocardial Infarction by Bioinformatics and Machine Learning: Insights into Inflammation and Immune Regulation
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1607096
- 195 views
Editorial
Published on 22 May 2025
Editorial: Bridging discovery and translation in novel biomarkers and big data-based biomedical studies for cancer management
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1620512
- 741 views
Review
Published on 22 May 2025
Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1615393
- 827 views
Review
Published on 21 May 2025
A comprehensive review of diagnostic approaches for hepatitis D
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1598784
- 869 views
Original Research
Accepted on 20 May 2025
Comprehensive Bioinformatics Analysis of the Common Mechanism of Atherosclerosis and Atrial Fibrillation: Emphasizing Mitochondrial Metabolic Disorder and Immune Inflammation
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1595048
- 218 views
Original Research
Published on 19 May 2025
Low‐Dose naltrexone restored TRPM3 ion channel function in natural killer cells from long COVID patients
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1582967
- 13,748 views
Original Research
Published on 16 May 2025
Integrating network pharmacology and experimental validation to reveal the anti-growth mechanism of panaxadiol against glioblastoma via calcium signaling
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1598413
- 740 views